In this issue:
Exercise may mitigate symptoms of CIPN in survivors of ovarian cancer
Does salpingectomy reduce the risk of ovarian cancer?
Rapid uptake of HRD testing in advanced epithelial ovarian cancer in the UK
Novel functional HRD assay allows prediction of response in HGSOC
What is the optimal number of NACT cycles for advanced disease?
NACT use is increasing in LGSOC in the US
Does limited-staging surgery confer inferior outcomes in very early-stage disease?
MDT practice determines treatment pathway
PAOLA-1: Front-line Olaparib + bevacizumab maintenance prolongs survival in HRD tumours
CAPRI: ceralasertib + Olaparib has activity in PARP inhibitor-resistant disease
Please login below to download this issue (PDF)